The recent pandemic and increasing frequency of infectious disease outbreaks due to climate change, urbanization, and increased human migration have drawn significant attention to nucleic acid amplification-based diagnostic technologies (NAAT). Currently, these technologies are mainly accessible only to trained workers in centralized facilities. There is a growing demand for home-based, extraction-free testing using crude samples, however, there are significant challenges in assay development for these point-of-care (POC) applications.

In this upcoming webinar, you will learn:

• Advances in isothermal amplification as an alternative to the current qPCR gold standard
• Advantages of loop-mediated isothermal amplification (LAMP) and nucleic acid sequence-based amplification (NASBA) for the development of the next generation of sensitive, affordable, mobile POC devices

Speakers:

William Ferreira, Ph.D., R&D Team Leader

Steve Hawkins, Ph.D., Product Marketing Manager